<code id='12E68EE71C'></code><style id='12E68EE71C'></style>
    • <acronym id='12E68EE71C'></acronym>
      <center id='12E68EE71C'><center id='12E68EE71C'><tfoot id='12E68EE71C'></tfoot></center><abbr id='12E68EE71C'><dir id='12E68EE71C'><tfoot id='12E68EE71C'></tfoot><noframes id='12E68EE71C'>

    • <optgroup id='12E68EE71C'><strike id='12E68EE71C'><sup id='12E68EE71C'></sup></strike><code id='12E68EE71C'></code></optgroup>
        1. <b id='12E68EE71C'><label id='12E68EE71C'><select id='12E68EE71C'><dt id='12E68EE71C'><span id='12E68EE71C'></span></dt></select></label></b><u id='12E68EE71C'></u>
          <i id='12E68EE71C'><strike id='12E68EE71C'><tt id='12E68EE71C'><pre id='12E68EE71C'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:explore    Page View:41

          Can the FDA be too flexible? How do you test a mechanical womb? And who decides what’s good enough for patients in need?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Lizzy Lawrence joins us to explain the promise of artificial wombs and the debate over how to ethically develop them. We also discuss a momentous upcoming meeting in which FDA will consider the thorny case of a potential medicine for ALS whose supporting evidence has polarized patients and physicians.

          advertisement

          For more on what we cover, here’s the latest on artificial womb technology; here’s more on the ALS debate; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          advertisement

          leisure time

          Trump demands the U.S. pay no more for drugs than other countries … again
          Trump demands the U.S. pay no more for drugs than other countries … again

          EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

          read more
          The problems with dementia villages
          The problems with dementia villages

          AdobeRecently,dementiavillageshavegainedpopularityinEuropeandAustraliaasanall-in-onesolutiontocaring

          read more
          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more

          Health tech investors get more selective as pandemic boom fades

          AdobeVenturefirmsbackinghealthtechstartupsaretelegraphingcautiousoptimismfor2024,advisingstartupstoe